Alpha-Pyrrolidinohexiophenone: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
| legal_UK = Class B |
| legal_UK = Class B |
||
| legal_US = |
| legal_US = |
||
| legal_status = |
| legal_status = Illegal in China and Sweden |
||
| routes_of_administration = oral, intranasal, vaporization, intravenous, rectal, sublingual,subcutaneous |
| routes_of_administration = oral, intranasal, vaporization, intravenous, rectal, sublingual,subcutaneous |
||
Line 44: | Line 44: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=16 | H=23 | N=1 | O=1 |
| C=16 | H=23 | N=1 | O=1 |
||
| molecular_weight = |
| molecular_weight = |
||
| smiles = C1(=CC=CC=C1)C(C(CCCC)N2CCCC2)=O |
| smiles = C1(=CC=CC=C1)C(C(CCCC)N2CCCC2)=O |
||
| InChI = |
| InChI = |
||
Line 54: | Line 54: | ||
}} |
}} |
||
'''α-Pyrrolidinohexiophenone''' ('''α-PHP''', '''alpha-PHP''', '''α-Pyrrolidinohexanophenone''', '''PV-7''') is a synthetic [[stimulant]] drug of the [[cathinone]] class developed in the 1960s<ref>{{cite web | url=https://www.google.com/patents/US3314970 | title=US Patent 3314970 - α-Pyrrolidino ketones | publisher=Ernst Seeger | accessdate=18 June 2015}}</ref> which has been reported as a novel [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/9001934 | title=α-Pyrrolidinohexanophenone | publisher=Cayman Chemical | accessdate=17 June 2015}}</ref> It is a longer chain homologue of [[alpha-Pyrrolidinopentiophenone|α-PVP]], having an extra carbon on the alkyl side chain, and is a [[structural isomer]] of [[pyrovalerone]].<ref>{{cite journal | url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602954/ | title=1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogs. A promising class of monoamine uptake inhibitors | author=Meltzer PC, Butler D, Deschamps JR, Madras BK. | journal=Journal of Medicinal Chemistry |date=February 2006 | volume=49 | issue=4 | pages=1420–1432 | doi=10.1021/jm050797a | pmid=16480278}}</ref> |
'''α-Pyrrolidinohexiophenone''' ('''α-PHP''', '''alpha-PHP''', '''α-Pyrrolidinohexanophenone''', '''PV-7''') is a synthetic [[stimulant]] drug of the [[cathinone]] class developed in the 1960s<ref>{{cite web | url=https://www.google.com/patents/US3314970 | title=US Patent 3314970 - α-Pyrrolidino ketones | publisher=Ernst Seeger | accessdate=18 June 2015}}</ref> which has been reported as a novel [[designer drug]].<ref>{{cite journal | url=http://link.springer.com/article/10.1007%2Fs11419-014-0238-5 | title=Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products | author=Nahoko Uchiyama, Yoshihiko Shimokawa, Maiko Kawamura, Ruri Kikura-Hanajiri, Takashi Hakamatsuka | journal=Forensic Toxicology | date=August 2014 | volume=32 | issue=2 | pages=266-281 | doi=10.1007/s11419-014-0238-5}}</ref><ref>{{cite journal | url=http://link.springer.com/article/10.1007/s11419-015-0295-4 | title=Identification and characterization of new designer drug 4-fluoro-PV9 and α-PHP in the seized materials | author=Milena Majchrzak, Marcin Rojkiewicz, Rafał Celiński, Piotr Kuś, Mieczysław Sajewicz | journal=Forensic Toxicology | date=October 2015 | doi=10.1007/s11419-015-0295-4}}</ref><ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/9001934 | title=α-Pyrrolidinohexanophenone | publisher=Cayman Chemical | accessdate=17 June 2015}}</ref> It is a longer chain homologue of [[alpha-Pyrrolidinopentiophenone|α-PVP]], having an extra carbon on the alkyl side chain, and is a [[structural isomer]] of [[pyrovalerone]].<ref>{{cite journal | url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602954/ | title=1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogs. A promising class of monoamine uptake inhibitors | author=Meltzer PC, Butler D, Deschamps JR, Madras BK. | journal=Journal of Medicinal Chemistry |date=February 2006 | volume=49 | issue=4 | pages=1420–1432 | doi=10.1021/jm050797a | pmid=16480278}}</ref> |
||
==Legality== |
==Legality== |
Revision as of 20:33, 21 October 2015
Clinical data | |
---|---|
Routes of administration | oral, intranasal, vaporization, intravenous, rectal, sublingual,subcutaneous |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H23NO |
Molar mass | 245.366 g·mol−1 |
3D model (JSmol) | |
| |
|
α-Pyrrolidinohexiophenone (α-PHP, alpha-PHP, α-Pyrrolidinohexanophenone, PV-7) is a synthetic stimulant drug of the cathinone class developed in the 1960s[1] which has been reported as a novel designer drug.[2][3][4] It is a longer chain homologue of α-PVP, having an extra carbon on the alkyl side chain, and is a structural isomer of pyrovalerone.[5]
Legality
Sweden's public health agency suggested to classify α-PHP as narcotic on June 1, 2015.[6]
As of October 2015 α-PHP is a controlled substance in China.[7]
See also
- α-PBP
- α-PPP
- α-Pyrrolidinopentiothiophenone (α-PVT)
- 4-Methyl-α-PHP
- Prolintane
- Methylenedioxypyrovalerone
References
- ^ "US Patent 3314970 - α-Pyrrolidino ketones". Ernst Seeger. Retrieved 18 June 2015.
- ^ Nahoko Uchiyama, Yoshihiko Shimokawa, Maiko Kawamura, Ruri Kikura-Hanajiri, Takashi Hakamatsuka (August 2014). "Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products". Forensic Toxicology. 32 (2): 266–281. doi:10.1007/s11419-014-0238-5.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Milena Majchrzak, Marcin Rojkiewicz, Rafał Celiński, Piotr Kuś, Mieczysław Sajewicz (October 2015). "Identification and characterization of new designer drug 4-fluoro-PV9 and α-PHP in the seized materials". Forensic Toxicology. doi:10.1007/s11419-015-0295-4.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "α-Pyrrolidinohexanophenone". Cayman Chemical. Retrieved 17 June 2015.
- ^ Meltzer PC, Butler D, Deschamps JR, Madras BK. (February 2006). "1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogs. A promising class of monoamine uptake inhibitors". Journal of Medicinal Chemistry. 49 (4): 1420–1432. doi:10.1021/jm050797a. PMID 16480278.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "23 nya ämnen kan klassas som narkotika eller hälsofarlig vara". Retrieved 29 June 2015.
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.